BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 21729690)

  • 1. Hepatitis C reactivation in patients who have diffuse large B-cell lymphoma treated with rituximab: a case report and review of literature.
    Nooka A; Shenoy PJ; Sinha R; Lonial S; Flowers CR
    Clin Lymphoma Myeloma Leuk; 2011 Oct; 11(5):379-84. PubMed ID: 21729690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis C virus infection prevalence and liver dysfunction in a cohort of B-cell non-Hodgkin's lymphoma patients treated with immunochemotherapy.
    Nosotti L; D'Andrea M; Pitidis A; Pimpinelli F; Dessanti ML; Pisani F; Vignally P; Petti MC
    Scand J Infect Dis; 2012 Jan; 44(1):70-3. PubMed ID: 21905952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical outcome in diffuse large B-cell lymphoma with hepatitis C virus infection in the rituximab era: a single center experience.
    Nishikawa H; Tsudo M; Osaki Y
    Oncol Rep; 2012 Sep; 28(3):835-40. PubMed ID: 22736295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis C virus and diffuse large B-cell lymphoma: Pathogenesis, behavior and treatment.
    Visco C; Finotto S
    World J Gastroenterol; 2014 Aug; 20(32):11054-61. PubMed ID: 25170194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis C and risk of lymphoma: results of the European multicenter case-control study EPILYMPH.
    Nieters A; Kallinowski B; Brennan P; Ott M; Maynadié M; Benavente Y; Foretova L; Cocco PL; Staines A; Vornanen M; Whitby D; Boffetta P; Becker N; De Sanjosé S
    Gastroenterology; 2006 Dec; 131(6):1879-86. PubMed ID: 17087949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis C virus and lymphoma.
    Paydas S
    Crit Rev Oncol Hematol; 2015 Mar; 93(3):246-56. PubMed ID: 25457774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Do hepatitis C Virus genotypes influence liver dysfunction following rituximab-containing regimens in patients with diffuse large B cell lymphoma?
    Toshikuni N; Maeda T; Ueda Y
    Acta Haematol; 2012; 127(3):178-81. PubMed ID: 22343527
    [No Abstract]   [Full Text] [Related]  

  • 8. Hepatitis C virus - associated B cell non-Hodgkin's lymphoma.
    Mihăilă RG
    World J Gastroenterol; 2016 Jul; 22(27):6214-23. PubMed ID: 27468211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low incidence of hepatitis B virus reactivation during chemotherapy among diffuse large B-cell lymphoma patients who are HBsAg-negative/ HBcAb-positive: a multicenter retrospective study.
    Ji D; Cao J; Hong X; Li J; Wang J; Chen F; Wang C; Zou S
    Eur J Haematol; 2010 Sep; 85(3):243-50. PubMed ID: 20491883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accelerated hepatitis C virus replication with rituximab treatment in a non-Hodgkin's lymphoma patient.
    Aksoy S; Abali H; Kilickap S; Erman M; Kars A
    Clin Lab Haematol; 2006 Jun; 28(3):211-4. PubMed ID: 16706940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis C infection is associated with hepatic toxicity but does not compromise the survival of patients with diffuse large B cell lymphoma treated with rituximab-based chemotherapy.
    Chen TT; Chiu CF; Yang TY; Lin CC; Sargeant AM; Yeh SP; Liao YM; Bai LY
    Leuk Res; 2015 Feb; 39(2):151-6. PubMed ID: 25524176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics and outcome of diffuse large B-cell lymphoma in hepatitis C virus-positive patients in LNH 93 and LNH 98 Groupe d'Etude des Lymphomes de l'Adulte programs.
    Besson C; Canioni D; Lepage E; Pol S; Morel P; Lederlin P; Van Hoof A; Tilly H; Gaulard P; Coiffier B; Gisselbrecht C; Brousse N; Reyes F; Hermine O;
    J Clin Oncol; 2006 Feb; 24(6):953-60. PubMed ID: 16418500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical outcome of HCV-positive patients with diffuse large B-cell lymphoma treated with rituximab-based chemotherapy.
    Salah-Eldin MA; Ebrahim MA; El-Sadda W
    Ann Hematol; 2014 Nov; 93(11):1903-11. PubMed ID: 24951125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HCV-associated B-cell non-Hodgkin lymphomas and new direct antiviral agents.
    Carrier P; Jaccard A; Jacques J; Tabouret T; Debette-Gratien M; Abraham J; Mesturoux L; Marquet P; Alain S; Sautereau D; Essig M; Loustaud-Ratti V
    Liver Int; 2015 Oct; 35(10):2222-7. PubMed ID: 26104059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rituximab-induced hepatitis C virus reactivation after spontaneous remission in diffuse large B-cell lymphoma.
    Hsieh CY; Huang HH; Lin CY; Chung LW; Liao YM; Bai LY; Chiu CF
    J Clin Oncol; 2008 May; 26(15):2584-6. PubMed ID: 18487576
    [No Abstract]   [Full Text] [Related]  

  • 16. Chemotherapy-induced hepatitis B reactivation in lymphoma patients with resolved HBV infection: a prospective study.
    Hsu C; Tsou HH; Lin SJ; Wang MC; Yao M; Hwang WL; Kao WY; Chiu CF; Lin SF; Lin J; Chang CS; Tien HF; Liu TW; Chen PJ; Cheng AL;
    Hepatology; 2014 Jun; 59(6):2092-100. PubMed ID: 24002804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiviral therapy is associated with a better survival in patients with hepatitis C virus and B-cell non-Hodgkin lymphomas, ANRS HC-13 lympho-C study.
    Michot JM; Canioni D; Driss H; Alric L; Cacoub P; Suarez F; Sibon D; Thieblemont C; Dupuis J; Terrier B; Feray C; Tilly H; Pol S; Leblond V; Settegrana C; Rabiega P; Barthe Y; Hendel-Chavez H; Nguyen-Khac F; Merle-Béral H; Berger F; Molina T; Charlotte F; Carrat F; Davi F; Hermine O; Besson C;
    Am J Hematol; 2015 Mar; 90(3):197-203. PubMed ID: 25417909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased hepatitis C viral load and reactivation of liver disease in HCV RNA-positive patients with onco-haematological disease undergoing chemotherapy.
    Coppola N; Pisaturo M; Guastafierro S; Tonziello G; Sica A; Iodice V; Sagnelli C; Ferrara MG; Sagnelli E
    Dig Liver Dis; 2012 Jan; 44(1):49-54. PubMed ID: 21885355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic toxicity and prognosis in hepatitis C virus-infected patients with diffuse large B-cell lymphoma treated with rituximab-containing chemotherapy regimens: a Japanese multicenter analysis.
    Ennishi D; Maeda Y; Niitsu N; Kojima M; Izutsu K; Takizawa J; Kusumoto S; Okamoto M; Yokoyama M; Takamatsu Y; Sunami K; Miyata A; Murayama K; Sakai A; Matsumoto M; Shinagawa K; Takaki A; Matsuo K; Kinoshita T; Tanimoto M
    Blood; 2010 Dec; 116(24):5119-25. PubMed ID: 20823454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver dysfunction after chemotherapy in lymphoma patients infected with hepatitis C.
    Dizdar O; Tapan U; Aksoy S; Harputluoglu H; Kilickap S; Barista I
    Eur J Haematol; 2008 May; 80(5):381-5. PubMed ID: 18221389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.